← FDA DRUG APPROVALS

FDA ANDA · ANDA074756

SELEGILINE HYDROCHLORIDE

Sponsor: COSETTE PHARMS NC

APPLICATION
ANDA074756
TYPE
ANDA
ORIGINAL APPROVAL
1998-11-25
LATEST ACTION
1998-11-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SELEGILINE HYDROCHLORIDEDiscontinued
SELEGILINE HYDROCHLORIDE 5MG · TABLET · ORAL

Approval history

1998-11-25OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →